Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%

Trials by Status

unknown117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completed

The Status of Immune Checkpoints at Gastrointestinal Cancer

NCT04566848
completed

Cytokine Levels of Patients Who Underwent Obesity Surgery

NCT04540263
completed

Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?

NCT04502940
completed

Immune Cell Subgroups in Covid 19 Patients

NCT04531319
completed

Cytokine Status of Covid-19 Patients

NCT04531345
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04566848

The Status of Immune Checkpoints at Gastrointestinal Cancer

Completed
NCT04540263

Cytokine Levels of Patients Who Underwent Obesity Surgery

Completed
NCT04502940

Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?

Completed
NCT04531319

Immune Cell Subgroups in Covid 19 Patients

Completed
NCT04531345

Cytokine Status of Covid-19 Patients

Completed
NCT03249636

New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6